Observational studies have implicated habitual sleep duration as a risk factor for mortality
and morbidity. Part of this association might be mediated by obesity, which has also been …

OBJECTIVES: Little evidence exists to support the common assertion that adult sleep
duration has declined. We investigated secular trends in sleep duration over the past 40 …

Cannabinoids, including the two main phytocannabinoids Δ 9-tetrahydrocannabinol (THC)
and cannabidiol (CBD), are being increasingly utilised as pharmacological interventions for …

Background: Previously published cohort studies in clinical populations have suggested that
obstructive sleep apnea (OSA) is a risk factor for mortality associated with cardiovascular …

Objective: To ascertain whether objectively measured obstructive sleep apnea (OSA)
independently increases the risk of all cause death, cardiovascular disease (CVD), coronary …

Background: Cross-sectional analyses of North American population-based cohorts and one
nonsignificant longitudinal analysis have suggested that obstructive sleep apnea (OSA) is a …

Introduction Electronic devices in the bedroom are broadly linked with poor sleep in
adolescents. This study investigated whether there is a dose-response relationship between …

Melatonin is commonly used for sleep and jetlag at low doses. However, there is less
documentation on the safety of higher doses, which are being increasingly used for a wide …

Short (≤ 6 hours) and long (> 9 hours) sleep durations are risk factors for mortality and
morbidity. To investigate whether the prevalences of short and long sleep durations have …

Rationale: Dyslipidemia is common in Obstructive Sleep Apnea (OSA). Postprandial
lipidemia (PPL) is a strong marker of cardiovascular risk. Evidence that OSA treatment …